The FDA panel voted to loosen restrictions on controversial peptides

A US Food and Drug Administration (FDA) advisory panel has voted to ease restrictions on controversial peptides that are popular online but have not been thoroughly tested for human use.

The panel narrowly ruled that specialty pharmacies can manufacture drugs including BPC-157, TB-500 and KPV, a major regulatory hurdle to making them available by prescription.

Peptides are small proteins that the body naturally produces and have long been used to treat diseases, including diabetes.

But since GLP-1s (weight loss drugs) became mainstream, unregulated injectable peptides have exploded in the online wellness community.

The FDA does not have to follow the panel’s recommendations, but often does.

Health Secretary Robert F. Kennedy has described himself as a “big fan” of the drug, and the Biden administration has promised to ease restrictions on them after shutting down the growing industry.

Peptides are short chains of amino acids or small proteins that the body produces naturally. They act as messengers, telling our cells what to do, and play a vital role in the health of our skin, immune system, and hormone regulation.

Online influencers have been marketing peptides in “stacks” for unproven uses, claiming that you can use them as a quick way to look younger, heal and rejuvenate your skin.

Certain peptides have become popular among teenagers on Tik Tok with unproven claims that they can help build muscle mass and improve your body.

Health experts have warned against using the drug, citing the lack of clinical trials on humans and the fact that the long-term effects of the ingredients are unknown.

BPC-157 is one of the most popular peptides among security influencers.

It is made from gut protein and is marketed online as beneficial for gut health, tissue repair and inflammation.

It has been studied in animals for its ability to aid in muscle healing.

The U.S. Anti-Doping Agency (ADA) says that “no one knows if there is a safe dose or if there is a way to safely treat certain conditions with this compound” because it has not been extensively studied in humans.

The peptide is banned for use in sports and is considered a banned substance by the World Anti-Doping Agency.

KPV is thought to be good for gut health, tissue repair – To control skin lesions such as acne and the immune system.

Both were a gray area when it came to regulation. They’re not illegal to buy or possess — and they’re widely available online — but they’re not approved for human use, so they’re not subject to the same quality controls that regulate drug manufacturing.

Panelist Elizabeth Rebelo, a pharmacist and anesthesiologist, told the committee she voted no on BPC-157 because of “lack of efficacy data” and “safety concerns,” Reuters news agency reported.

Those who voted yes cited “greater benefit” and “medical freedom” as reasons for their decision.

Several people who work for clinics or businesses that sell the peptide will be on the panel, which will continue deliberations on Friday.

BPC-157 and KPV are among the seven peptides the panel is considering to remove restrictions and allow pharmacies to produce compounding drugs not available from conventional drugmakers.

The peptide restrictions were introduced under the Biden administration when FDA officials found the drugs did not meet safety standards. Kennedy worked to reverse those restrictions.